Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction

Obesity (Silver Spring). 2014 Aug;22(8):1838-46. doi: 10.1002/oby.20771. Epub 2014 Apr 24.

Abstract

Objective: To assess the rapid improvement of insulin sensitivity and β-cell function following biliopancreatic diversion with duodenal switch (BPD-DS) and determine the role played by caloric restriction in these changes.

Methods: Standard meals were administrated before and on day 3, 4, and 5 after BPD-DS to measure total caloric intake, glucose excursion, insulin sensitivity, and secretion in matched type 2 diabetes and normoglycemic (NG) subjects. In a second set of study, other subjects with type 2 diabetes had the same meal tests prior to and after a 3-day caloric restriction identical to that observed after BPD-DS and then 3 days after actually undergoing BPD-DS.

Results: Improvement of HOMA-IR occurred at day 3 after BPD-DS in diabetes and after 3 days of caloric restriction. The disposition index (DI) improved rapidly in diabetes after BPD-DS and to a similar extent after caloric restriction. DI was higher and did not change after BPD-DS in NG. Changes in glucagon-like peptide-1, gastric inhibitory peptide, peptide tyrosine tyrosine, ghrelin, and pancreatic polypeptide levels were not associated with modulation of DI in the participants.

Conclusions: Caloric restriction is the major mechanism underlying the early improvement of insulin sensitivity and β-cell function after BPD-DS in type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biliopancreatic Diversion*
  • Blood Glucose / analysis
  • Caloric Restriction*
  • Diabetes Mellitus, Type 2 / complications
  • Duodenum / surgery
  • Female
  • Gastric Inhibitory Polypeptide / blood
  • Ghrelin / blood
  • Glucagon-Like Peptide 1 / blood
  • Glucose Tolerance Test
  • Humans
  • Insulin / metabolism*
  • Insulin Resistance*
  • Insulin Secretion
  • Insulin-Secreting Cells / cytology
  • Male
  • Middle Aged
  • Obesity, Morbid / surgery
  • Peptide YY / blood
  • Pilot Projects

Substances

  • Blood Glucose
  • Ghrelin
  • Insulin
  • Peptide YY
  • Gastric Inhibitory Polypeptide
  • Glucagon-Like Peptide 1